Houston Methodist partners with HealthLeap to launch ai-driven clinical screening platform. What you should know. * Clinical AI startup HealthLeap has announced the systemwide deployment of its AI-driven clinical screening platform across Houston Methodist. * The rollout addresses a pervasive, invisible clinical liability: while up to 50% of hospitalized patients are at risk for inadequate nutrition, fewer than 9% are formally diagnosed nationwide due to static screening tools. * Moving past rigid admission-day questionnaires, HealthLeap continuously analyzes 100% of adult inpatient charts daily, scraping clinical notes, lab results, vitals, active medication orders, and problem lists. * The platform functions natively within existing workflows, automatically pushing prioritized, actionable risk scores and alerts directly to care teams to accelerate targeted clinical intervention. * The enterprise-wide collaboration will track immediate clinical, operational, and financial outcomes, heavily measuring improvements in patient length of stay and documentation accuracy. Why Houston Methodist deployed HealthLeap systemwide. The inpatient care and clinical operations frameworks across the American hospital landscape are wrestling with a pervasive, yet deeply under-recognized challenge: disease-related malnutrition. While healthcare organizations have spent the last decade digitizing workflows and building data infrastructures, clinical protocols for identifying metabolic and nutritional decline have remained fundamentally static. The current baseline relies heavily on manual assessments and uncalibrated, admission-day questionnaires filled out by overextended nursing staff. Because these administrative checkpoints are entirely static, they fail to capture patients whose physiological baselines deteriorate over the course of a complex hospital stay. The statistical reality of this documentation and screening deficit is stark. National data highlights that although 30% to 50% of hospitalized inpatients are actively at risk for inadequate nutrition, only about 9% are formally diagnosed during their hospitalization. When these high-acuity risks go entirely unrecorded, it triggers a costly cascade of clinical and operational liabilities. Unmanaged nutritional deficits delay standard wound healing, compromise immune resilience, accelerate muscle wasting, and lengthen overall hospital stays. For hospital C-suites navigating thin operating margins and tightening value-based care penalties, closing this gap requires moving past traditional clinical decision alerts to deploy an automated, continuous safety net that turns unstructured chart data into immediate diagnostic action. To eliminate this systemic blind spot, clinical AI pioneer HealthLeap has announced the systemwide deployment of its AI-driven clinical screening platform across Houston Methodist's entire enterprise network. By embedding a machine-learning safety net directly inside existing workflows, the partnership aims to screen 100% of inpatients from admission through discharge, ensuring at-risk individuals are flagged long before acute complications manifest. Operating upstream: the mechanics of continuous risk Ingestion. The core technology strategy driving HealthLeap rejects the transaction-heavy approach of standalone administrative chat applications or basic alert triggers. Instead, the platform functions as an integrated, chart-aware system of record that operates entirely in the background of the Electronic Health Record (EHR) system. Rather than requiring a clinician to launch an external portal or manually query a separate application, the platform surfaces data natively where care teams already work. The platform's cloud-native clinical intelligence model continuously analyzes multi-vector data fields across every single adult chart: * Deep Semantic Ingestion: The AI sweeps through unstructured clinical text notes, longitudinal laboratory results, fluctuating vitals, active medication and dietary orders, and changing problem lists. * Real-Time Risk Ranking: As physiological variables drift, the platform evaluates the complete picture of patient risk over time, risk-ranking patients based on the urgency of required nutrition intervention. * Actionable Workflow Pushes: Programmatic, optimized risk scores and prioritization alerts are injected directly into the native EHR workspace, equipping dietitians and physicians to stabilize high-risk cohorts sooner. "At Houston Methodist, we are focused on strengthening how we identify patients who may benefit from additional nutrition support," said Michelle Stansbury, associate chief innovation officer and VP of IT applications at Houston Methodist. "By incorporating advanced screening tools into the clinical workflow, we can help care teams recognize risk earlier, intervene sooner, and support more timely recovery for patients." Aligning clinical quality with operational defensibility. The commercial rationale driving HealthLeap's systemwide adoption extends beyond direct clinical quality into enterprise financial sustainability. In a margin-compressed healthcare economy, ensuring that documentation accurately reflects a patient's true severity of illness (SOI) is an absolute operational priority. By continuously analyzing the full clinical picture, HealthLeap supports consistent chart documentation, aligning frontline care with backend hospital coding. This eliminates gaps in severity tracking, optimizes reimbursement accuracy for complex care, and provides an immediate defense against retroactive payer claims denials. As the only commercially available, peer-reviewed validated platform in this category, HealthLeap has carved out a defensive clinical niche. The company operates upstream of traditional point solutions, identifying vulnerabilities before standard administrative or documentation processes fail. Josiah Meyer, Chief Executive Officer and Co-founder of HealthLeap, highlighted the prestige of the collaboration, noting that the enterprise rollout provides deep market validation for startups focused on transforming invisible clinical risks into measurable operational and outcomes-driven wins. Moving forward, HealthLeap and Houston Methodist are tracking the long-term impact of the deployment across a strict matrix of clinical, operational, and financial KPIs, focusing heavily on reducing length of stay and maximizing screening consistency.

HealthLeap announces deployment of its AI nutrition risk identification platform at Houston Methodist. San Francisco, CA - WEBWIRE - Thursday, June 25, 2026 Gaps in identifying patients at risk for inadequate nutrition remain a widespread and often under-recognized challenge across hospital systems. Today, HealthLeap announced it has launched its AI-driven clinical screening platform across Houston Methodist's system to help address this issue earlier and more consistently among at-risk inpatients. Although only about nine percent of hospitalized patients nationwide are formally diagnosed with nutrition-related conditions, an estimated 30% to 50% may be at risk. When these needs go unrecognized, it can delay intervention and contribute to longer hospital stays, slower recovery, and added strain on both patients and health systems. Strengthening early identification is increasingly viewed as a key component of more proactive, patient-centered care. "At Houston Methodist, we are focused on strengthening how we identify patients who may benefit from additional nutrition support," said Michelle Stansbury, associate chief innovation officer and VP of IT applications at Houston Methodist. "By incorporating advanced screening tools into the clinical workflow, we can help care teams recognize risk earlier, intervene sooner, and support more timely recovery for patients." Traditional nutrition screening often relies on manual assessments and admission-day questionnaires, which may not capture changes in patient risk over time and can make it difficult to consistently identify patients who need nutrition intervention early. By integrating AI-driven screening and prioritization into existing workflows, HealthLeap is designed to help health systems identify at-risk patients earlier and surface those who may need attention most urgently. Earlier identification allows care teams to proactively help stabilize patients sooner while supporting the most efficient care delivery. HealthLeap's validated AI system screens 100% of inpatients daily, from admission through discharge. This continuous visibility is intended to give clinicians a more complete picture of patient risk over time, enabling earlier interventions that may help reduce complications, prevent avoidable delays in care, and support shorter lengths of stay. It also supports more consistent documentation and alignment between clinical care and hospital operations, leading to more accurate capture of patients' severity. "It's an honor to support Houston Methodist in advancing an approach that strengthens early identification and proactive patient care," said Josiah Meyer, Chief Executive Officer and Co-founder of HealthLeap. HealthLeap and Houston Methodist will track the impact of this approach across both clinical, operational, and financial measures, including length of stay and the consistency of identifying and documenting patients who may benefit from nutrition-related care. About HealthLeap HealthLeap is an AI-powered clinical screening platform that surfaces inpatient risks for care teams to act on. The company initially started with addressing malnutrition, a condition estimated to affect up to 50% of hospitalized patients yet formally identified in fewer than 9% today. HealthLeap continuously reviews every adult inpatient throughout hospitalization, prioritizes patients based on nutrition risk, and integrates those insights directly into existing clinical workflows to support earlier assessment and intervention. As the only commercially available peer-reviewed validated platform in this category, HealthLeap operates upstream of traditional clinical decision support and documentation workflows to help health systems identify patients before downstream processes can engage. HealthLeap combines frontier AI with on-the-ground implementation and clinical services to translate risk signals into measurable outcomes. HealthLeap partners with leading health systems to improve patient outcomes and support more sustainable hospital operations. Learn more at https://www.healthleap.ai/. WebWireID356725 * Contact Information - Riley Munks - PR Advisor - Activate PR - https://www.activate-pr.com/ - [email protected] This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted. Distribute your news. * Every day, hundreds of individuals and companies choose WebWire to distribute their news. * WebWire places your news within numerous highly trafficked news search engines generating leads and publicity. * Submit Your Release Now!